相关实验视频
Updated: Jan 14, 2026

10:49
Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
7.0K
探索 lncRNA 在不同重复扩张障碍中的 pleiotropic 作用
Soumalya Das1, Shubhi Khandelwal1, Sakshi Shukla1
1Mehta Family School of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, 453552, India.
Biochimica et biophysica acta. Molecular basis of disease
|October 23, 2025
概括
长非编码RNAs (lncRNAs) 是重复扩张障碍 (REDs) 等疾病的关键调节者. 调节lncRNA活性为这些复杂的遗传疾病提供了潜在的新疗法.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 长非编码RNAs (lncRNAs) 是基因表达和表观遗传修饰的关键调节者.
- 重复扩张障碍 (REDs) 涉及异常的重复扩张,导致分子干扰和疾病病理.
研究的目的:
- 审查四个关键lncRNAs (NEAT1,TUG1,MEG3,MALAT1) 在REDs发展中的动态作用.
- 探索 lncRNAs 作为治疗标和 REDs 的诊断生物标记物的潜力.
主要方法:
- 关于 lncRNAs 和 REDs 的最新研究的文献综述.
- 在各种RED中分析NEAT1,TUG1,MEG3和MALAT1的参与.
- 讨论基于 lncRNA 的疗法的挑战和未来方向.
主要成果:
- 包括NEAT1,TUG1,MEG3和MALAT1在内的lncRNAs显著影响REDs的发展.
- 这些lncRNAs调节涉及RED病理生理学的多种生物化学途径.
- 尽管具有治疗潜力,但临床应用面临着免疫性和分娩等挑战.
结论:
- lncRNAs在REDs的发病过程中发挥着至关重要的非遗传作用.
- 针对 lncRNA 活动为新型 RED 治疗提供了一个有前途的途径.
- 克服目前的局限性对于实现 lncRNAs 在 REDs 中的临床实用性至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs
3.5K
3.5K
Non-LTR Retrotransposons
13.2K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.2K
Alternative RNA Splicing
24.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.7K
RNA Splicing
60.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.3K
Pleiotropy
43.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.2K

